The nation of Zimbabwe has declined a substantial American health deal valued at 367 million US dollars (£272m) spanning five years over the United States' request for sensitive data.
This move became public after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
A government representative later stated that the United States was requesting health data for research and commercial gain while was not willing to share the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for further talks to secure a deal agreeable to all parties so the nation's vital HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement following legal challenges were filed about the security of Kenyans' health data.
After resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and accountability.
As per statements, 16 nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to share its biological resources and data indefinitely, without any equivalent assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our people if a future disease outbreak arise."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks already set up through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.
"This framework is intended to ensure that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how future collaboration could be designed in a manner that honours the independence and dignity of both nations."
Medical Community Response
A leading public health body stated it acknowledged the official position, but suggested that talks need to persist since much of the nation's HIV programmes relied on foreign aid.
"In cases where technical issues arise, including those relating to information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group commented.
The situation emphasises the complex debate between accepting much-needed foreign assistance and protecting local interests in an ever more data-driven world.